Experiences during ART | Probable depression | Moderate/severe anxiety | ||
---|---|---|---|---|
ORu (95% CI) | ORaa (95% CI) | ORu (95% CI) | ORab (95% CI) | |
Positive experiences | ||||
 Increased CD4 cell count | 1.52 (0.50, 6.57) | – | 0.84 (0.27, 3.69) | – |
 Improved physical health | 0.42 (0.21, 0.88)* | 0.63 (0.28, 1.47) | 0.29 (0.13, 0.68)** | 0.31 (0.12, 0.84)* |
 Improved relationships with sexual partners | 0.34 (0.10, 0.89)* | 0.25 (0.06–0.73)* | 0.28 (0.04, 0.98)†| 0.17 (0.02, 0.71)* |
 Regained self-confidence | 0.30 (0.16, 0.60)*** | 0.40 (0.19–0.87)* | 0.36 (0.16, 0.82)* | 0.47 (0.19, 1.21) |
Negative experiences | ||||
 Side effects of ART | 2.16 (1.10, 4.40)* | 2.07 (0.99–4.51)†| 3.59 (1.48, 10.05)** | 3.49 (1.35, 10.38)* |
 AIDS-related symptoms | 2.00 (0.92, 4.14)†| 3.15 (1.30–7.57)** | 2.15 (0.84, 5.09)†| 2.82 (0.96, 8.04)†|
 Inconvenience in daily life due to ART use | 1.37 (0.63, 3.33) | – | 4.04 (1.16, 25.54)†| 5.74 (1.36, 41.92)* |
 Exposure of HIV-positive status due to ART use | 0.65 (0.25, 1.45) | – | 1.29 (0.48, 3.08) | – |